The miracles of science™

Select Industry

DuPont Biotechnology website

Biotechnology Position Statements

Consistent with Corporate Core Values, our Biotechnology Positions are further confirmation of the DuPont commitment to comprehensive stewardship of biotechnology as we leverage it for beneficial use long term. We believe in a prudent approach that includes caution and care—that is, we will carefully consider the wishes of society, protection of the environment, need for increased productivity and general improvement in the quality of life as we develop biotechnology products. This belief directly influences our positions on matters of public policy, interest or concern. We also believe in continuous learning and improvement and will address emerging issues and adjust as needed. Click here for a printer-friendly version of Biotechnology Position Statements.


  1. Biodiversity
    Protection of the world's biodiversity is an important societal need, as well as a critical requirement for developing new products. As part of our corporate commitment to sustainable growth, DuPont seeks to conserve and protect natural resource biodiversity; consider concerns of local communities in the selection, design, production and introduction of our products; and publicly advocate positions consistent with this commitment..

  2. Ecosystem Monitoring
    DuPont supports developing a better understanding of ecosystems so any potential impact of biotechnology products can be monitored as needed. DuPont believes public/private collaboration is the best approach to obtain the needed data.

  3. Global Regulatory Systems
    DuPont believes that a consistent, science-based, risk-focused, safety assessment and regulatory review is the most appropriate means to protect human health, animal health and the environment. DuPont believes effective regulation is a key to maximizing the acceptance of the technology.

  4. Labeling of Biotech-Derived Products
    DuPont complies with each country's labeling requirements of biotech-derived products and believes in all cases the label should be verifiable, non-discriminatory and not misleading.

  5. Product Stewardship
    DuPont will use the best scientific information to ensure a rigorous and comprehensive stewardship process in its research, product development and commercialization efforts.

  6. Safety Risk Assessment
    DuPont uses safety risk assessments to understand the potential impacts of its products on human health and the environment.

Plant Biotechnology

  1. Allergens
    Prior to commercialization of biotechnology-derived food or feed products, DuPont will undertake a thorough evaluation of allergenic potential and other health effects, using the most appropriate science available.

  2. Antibiotic Resistance Markers
    Genes conferring resistance to antibiotics are not present in DuPont’s proprietary commercial seed that has been developed through biotechnology.

  3. Coexistence of Multiple Agricultural Practices
    DuPont serves diverse farming practices (biotech, conventional, identity preserved, organic) with products, services and information that enable farmers to determine their marketing opportunities and adopt the agricultural practices that best fit their individual needs.

  4. Commercialization of New Commodity Grain Products
    DuPont will offer new traits to customers when the required regulatory reviews have been completed in the domestic market, and when specific conditions of the key export market have been met (import approval or adoption of international agreements.) DuPont advocates an appropriate level of stewardship to enhance the movement of the commodity grain channel.

  5. Detection Methods
    DuPont makes detection methods available for all of our proprietary biotech traits in commodity products upon commercialization.

  6. Farmer Saved Seed
    DuPont will use biotechnology to protect the value of our traits and intellectual property rights without interfering with the traditional practice of saving seed by farmers.

  7. Genes from Humans or Animals
    Genes from humans and animals are not present in DuPont's proprietary commercial seed that has been developed through biotechnology.

  8. Gene Switches
    DuPont will incorporate gene switches in seed products where it believes opportunities exist to produce beneficial results, e.g., controlling pollen flow to prevent genes from escaping into weedy relatives.

  9. Integrated Pest Management
    DuPont supports the use of Integrated Pest Management (IPM), including responsible monitoring and use of pest control methods and tools to manage the development of pest populations. We believe pest control options developed through biotechnology offer additional tools for use in IPM systems.

  10. Low-Level Presence
    DuPont supports regulation of low-level presence (LLP) that is scientifically sound and appropriate to facilitate global trade throughout the food chain. Specifically, we support LLP policies that: prohibit the occurrence of inserted genes that present a verifiable unacceptable risk and the occurrence of inserted genes wherein presence of the gene and/or its gene products cannot be scientifically assessed for adverse effects on human or animal health or the environment. Additionally, we support policies which permit LLP where the gene, protein and/or DNA meet applicable regulatory safety standards.

  11. Non-Target Organisms
    DuPont will conduct risk assessments of our biotech-derived traits to identify impacts on non-target organisms as specified by the regulatory agencies.

  12. Plant-Made Pharmaceutical and Industrial Products
    DuPont currently does not have commercial plant-made products developed solely for pharmaceutical or industrial uses.